Variable | Subgroup | Mild OSA (RR with 95% CI) | P value for mild OSA | Moderate OSA (RR with 95% CI) | P value for moderate OSA | Severe OSA (RR with 95% CI) | P value for severe OSA |
Country | USA | 1.00 (0.85 to 1.17) | 0.977 | 1.14 (0.99 to 1.32) | 0.064 | 1.90 (1.35 to 2.67) | <0.001 |
Other | 1.02 (0.19 to 5.52) | 0.982 | 1.44 (0.83 to 2.50) | 0.198 | 2.35 (1.52 to 3.65) | <0.001 | |
USA versus other | 0.98 (0.18 to 5.32)* | 0.982 | 0.79 (0.45 to 1.40)* | 0.422 | 0.81 (0.46 to 1.41)* | 0.453 | |
Mean age | ≥60 | 0.96 (0.86 to 1.08) | 0.540 | 1.13 (0.97 to 1.33) | 0.117 | 1.78 (1.23 to 2.57) | 0.002 |
<60 | 1.40 (0.73 to 2.70) | 0.315 | 1.51 (0.94 to 2.41) | 0.086 | 2.31 (1.64 to 3.24) | <0.001 | |
≥60 versus <60 | 0.69 (0.35 to 1.33)* | 0.265 | 0.75 (0.46 to 1.23)* | 0.252 | 0.77 (0.47 to 1.27)* | 0.309 | |
Gender | Male | 0.92 (0.73 to 1.15) | 0.455 | 1.10 (0.85 to 1.42) | 0.449 | 1.81 (1.14 to 2.89) | 0.012 |
Female | 1.97 (0.47 to 8.25) | 0.353 | 1.36 (0.67 to 2.76) | 0.399 | 1.98 (0.64 to 6.06) | 0.234 | |
Male versus female | 0.47 (0.11 to 1.99)* | 0.304 | 0.81 (0.38 to 1.72)* | 0.581 | 0.91 (0.27 to 3.08)* | 0.885 | |
BMI | ≥30 | 1.75 (0.88 to 3.49) | 0.111 | 1.70 (0.94 to 3.07) | 0.079 | 2.72 (1.80 to 4.10) | <0.001 |
<30 | 0.96 (0.86 to 1.07) | 0.449 | 1.14 (0.99 to 1.31) | 0.078 | 1.80 (1.36 to 2.38) | <0.001 | |
≥30 versus <30 | 1.82 (0.91 to 3.66)* | 0.092 | 1.49 (0.81 to 2.74)* | 0.198 | 1.51 (0.92 to 2.49)* | 0.104 | |
Disease statues | Healthy | 1.00 (0.85 to 1.17) | 0.977 | 1.16 (1.01 to 1.33) | 0.034 | 2.12 (1.53 to 2.94) | <0.001 |
Other | 1.02 (0.19 to 5.52) | 0.982 | – | – | 1.96 (1.01 to 3.81) | 0.047 | |
Healthy versus Other | 0.98 (0.18 to 5.32)* | 0.982 | – | – | 1.08 (0.52 to 2.27)* | 0.835 | |
Follow-up duration | ≥6 | 0.96 (0.86 to 1.07) | 0.449 | 1.14 (0.99 to 1.31) | 0.064 | 2.06 (1.43 to 2.95) | <0.001 |
<6 | 1.75 (0.88 to 3.49) | 0.111 | 1.74 (0.87 to 3.49) | 0.120 | 2.10 (1.39 to 3.17) | <0.001 | |
≥6 versus <6 | 0.55 (0.27 to 1.10)* | 0.092 | 0.66 (0.32 to 1.33)* | 0.242 | 0.98 (0.57 to 1.70)* | 0.945 |
*Reported as ratio of RR and 95% CI.
BMI, body mass index; MACES, major adverse cardiac events; OSA, obstructive sleep apnoea; RR, relative risk.